Abstract:Ethnopharmacological relevance: Curcumin is a bright yellow chemical produced by plants of the Curcuma longa species. Chemically, curcumin is a diarylheptanoid, belonging to the group of curcuminoids. The therapeutic potential of curcumin has been widely investigated, including its utilization in various of cardiovascular diseases. However, its effect in cardiac remodeling post myocardial infarction and underlying mechanism remains to be uncover. Aim: To evaluate the therapeutic effect and underlying mechanism of curcumin on cardiac fibrosis after myocardial infarction via macrophage-fibroblast crosstalk. Methods: Male C57BL/6 (C57) mice were subjected to left anterior descending coronary artery ligation to establish myocardial infarction and intragastrically fed vehicle or curcumin (50 mg/kg or 100 mg/kg) for 4 weeks. In parallel, neonatal rat cardiac fibroblasts were isolated and co-cultured with liposaccharide (LPS- or LPS+) curcumin-treated macrophages, followed by TGF-β stimulation for 24 h. Cardiac function was determined by 2-dimensional echocardiography, and cardiac fibrosis was measured by picrosirius red staining. Apoptosis of macrophages was investigated by flow cytometry; all pro-fibrotic protein expression (EDA-Fibronectin, Periostin, Vimentin, and α-SMA) as well as TGF-βR1 downstream signaling activation reflected by phosphorylated SMAD2/3 (p-SMAD2 and p-SMAD3) were demonstrated by western blotting. Results: Curcumin significantly ameliorated the inflammation process subsequent to myocardial infarction, reflected by decreased expression of CD68+ and CD3+ cells, accompanied by dramatically improved cardiac function compared with the placebo group. In addition, cardiac fibrosis is inhibited by curcumin administration. Interestingly, no significant reduction in fibrotic gene expression was observed when isolated cardiac fibroblasts were directly treated with curcumin in vitro; however, pro-fibrotic protein expression was significantly attenuated in CF, which was co-cultured with LPS-stimulated macrophages under curcumin treatment compared with the placebo group. Mechanistically, we discovered that curcumin significantly downregulated pro-inflammatory cytokines in macrophages, which in turn inhibited IL18 expression in co-cultured cardiac fibroblasts using bulk RNA sequencing, and the TGF-β1-p-SMAD2/3 signaling network was also discovered as the eventual target downstream of IL18 in curcumin-mediated anti-fibrosis signaling. Conclusion: Curcumin improves cardiac function and reduces cardiac fibrosis after myocardial infarction. This effect is mediated by the inhibition of macrophage-fibroblast crosstalk in the acute phase post-MI and retrained activation of IL18-TGFβ1-p-SMAD2/3 signaling in cardiac fibroblasts.

Glucocorticoid Ameliorates Early Cardiac Dysfunction after Coronary Microembolization and Suppresses TGF-β1/Smad3 and CTGF Expression.

Mast Cell Contributes to Cardiomyocyte Apoptosis after Coronary Microembolization

Assessment of the Acute Effects of Glucocorticoid Treatment on Coronary Microembolization Using Cine, First-Pass Perfusion, and Delayed Enhancement Mri

Tnf-Alpha-Induced Cardiomyocyte Apoptosis Contributes To Cardiac Dysfunction After Coronary Microembolization In Mini-Pigs

[Effect of acute coronary microembolization on microvascular injury and myocardial endothelin-1 levels].

Geniposide Alleviates Pressure Overload in Cardiac Fibrosis with Suppressed TGF-β1 Pathway

Left Ventricular Remodeling with Preserved Function after Coronary Microembolization: the Effect of Methylprednisolone.

Abstract 13957: TNF-α/MiR-133a Involved in Myocardial Leukocytes Infiltration and Cardiac Dysfunction on the Early Phase of Coronary Microembolization

Abstract 13434: Cardioprotection of Rosuvastatin Against Cardiac Dysfunction after Coronary Microembolization Via Alleviating Inflammatory Induced Microinfarctions

Cardiac Mast Cells Accumulation and Degranulation Contribute to Collagen Deposition after Coronary Microembolization

THE IMPACT OF CARDIAC RESYNCHRONISATION THERAPY ON TGF-β 1 SIGNAL PATHWAY IN ISCHAEMIC CARDIOMYOPATHY

Menstrual Blood Stem Cells Attenuate Post-Infarction Myocardial Fibrosis Via Inhibiting Endothelial to Mesenchymal Transition (Endmt)

Transplantation of Endothelial Progenitor Cells in the Treatment of Coronary Artery Microembolism in Rats

Role of high-mobility group B1 in myocardial injury induced by coronary microembolization in rats

Transglutaminase 2 inhibition ameliorates cardiac fibrosis in myocardial infarction by inducing M2 macrophage polarization in vitro and in vivo

Curcumin Ameliorates Cardiac Fibrosis by Regulating Macrophage-Fibroblast Crosstalk via IL18-P-SMAD2/3 Signaling Pathway Inhibition

Tranilast stabilizes the accumulation and degranulation of resident mast cells while reducing cardiomyocyte apoptosis in a swine model of coronary microembolisation.

Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization.

Effects of Methylprednisolone on Myocardial Function and Microcirculation in Post-resuscitation: A Rat Model

Abstract 13754: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Alleviate Fibrosis by Reducing Energy Production of Cardiac Fibroblast via Glutamate Metabolism Regulation

Fatty acid β‐oxidation and mitochondrial fusion are involved in cardiac microvascular endothelial cell protection induced by glucagon receptor antagonism in diabetic mice